UOB Kay Hian Research sees stock market consolidating in 3Q

TheStar Fri, Jul 10, 2020 10:40am - 3 years View Original


Duopharma Biotech products on display. The company is among the mid-cap stocks favoured by UOB Kay Hian Malaysia Research.

KUALA LUMPUR: UOB Kay Hian Malaysia Research expects the stock market to move into a consolidation mode following a spectacular recovery into a bull territory from a global Covid-19 outbreak-induced bear market.

“We expect sentiment in 3Q20 to be affected by a poor economic recovery and consumption, sharply reduced retail investor participation, and internal political bickering, ” it said in its strategy outlook on Friday.

Its strategy prescription is to immunise the portfolio with financially resilient or growth stocks and/or sustain generous dividends.

...

Full Article on TheStar

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

BAT 8.160
DPHARMA 1.190
GENM 2.640
GENTING 4.550
GTRONIC 1.260
KOSSAN 2.120
MRCB 0.690
PPB 15.940
SCIENTX 4.110
SENTRAL 0.800
TENAGA 11.840
TOPGLOV 0.845
YINSON 2.380

Comments

Login to comment.